Use of virginiamycin as a growth promoter
Barrow, P.A.
Veterinary Record 143(17): 483-484
1998
ISSN/ISBN: 0042-4900 PMID: 9829311 Document Number: 489607
Document emailed within 1 workday
Related Documents
De Wilde, R.O. 1984: Comparison of virginiamycin and salinomycin as growth promoters in growing-fattening pigs Deutsche Tierärztliche Wochenschrift 91(1): 22-24Perez-Sanchez, C.; Budhram-Mahadeo, V.S.; Latchman, D.S. 2002: Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter Nucleic Acids Research 30(22): 4872-4880
Pratt, J.H. 1986: Hormone growth promoter ban Veterinary Record 119(20): 511
Lynch, M.J.; Pelosi, L.; Carboni, J.M.; Merwin, J.; Coleman, K.; Wang, R.C.; Lin, P.F.; Henry, D.L.; Brattain, M.G. 1993: Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET Cancer Research 53(17): 4041-4047
Sa-nguanmoo, P.; Vejchapipat, P.; Chongsrisawat, V.; Chirathaworn, C.; Honsawek, S.; Theamboonlers, A.; Poovorawan, Y. 2007: Analysis of connective tissue growth factor promoter polymorphism in Thai children with biliary atresia Journal of the Medical Association of Thailand 90(2): 251-257
Matsuzawa, Y.; Semba, K.; Kawamura-Tsuzuku, J.; Sudo, T.; Ishii, S.; Toyoshima, K.; Yamamoto, T. 1991: Characterization of the promoter region of the c-yes proto-oncogene: the importance of the GC boxes on its promoter activity Oncogene 6(9): 1561-1567
Kinoshita, T.; Takahashi, I.; Kobayashi, E.; Tamaoki, T.; Irie, K.; Koshimizu, K.; Osato, T. 1990: Suppression by protein kinase C inhibitors of tumor promoter enhancement of Epstein-Barr virus-induced growth transformation Anticancer Research 10(4): 1051-1054
Kravatskaia, G.I.; Kravatskiĭ, I.V.; Mil'chevskiĭ, I.V.; Esipova, N.G. 2007: The specificity in promoter recognition by the Bacillus subtilis RNA polymerase deltaA and deltaH holoenzymes is connected with periodicities in the promoter nucleotide sequences Biofizika 52(6): 965-971
Weigert, C.; Brodbeck, K.; Bierhaus, A.; Häring, H.U.; Schleicher, E.D. 2003: c-Fos-driven transcriptional activation of transforming growth factor beta-1: inhibition of high glucose-induced promoter activity by thiazolidinediones Biochemical and Biophysical Research Communications 304(2): 301-307
Miller, C.R.; Philip, J.R.; Free, S.M.; Landis, L.M. 1972: Virginiamycin for prevention of swine dysentery Veterinary Medicine-Small Animal Clinician 67(11): 1246-1248
Gottschall, D.W.; Wang, R.; Kingston, D.G. 1988: Virginiamycin metabolism in cattle rumen fluid Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(6): 804-812
Rønne, H.; Jensen, J.C. 1992: Virginiamycin susceptibility of Serpulina hyodysenteriae, in vitro and in vivo Veterinary Record 131(11): 239-240
Boon, B.; Gilbert, M.; Lamy, F. 1973: Study of plasma and urinary levels of virginiamycin in humans Therapie 28(2): 367-377
Olson, L.D.; Rodabaugh, D.E. 1977: Evaluation of virginiamycin in feed for treatment and retreatment of swine dysentery American Journal of Veterinary Research 38(10): 1485-1490
Seth, A.; Robinson, L.; Thompson, D.M.; Watson, D.K.; Papas, T.S. 1993: Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody Oncogene 8(7): 1783-1790
Williams, B.J.; Shively, J.E. 1978: In vitro antitreponemal activities of carbadox, virginiamycin, olaquindox, and tylosin as indices of their effectiveness for preventing swine dysentery Veterinary Medicine-Small Animal Clinician 73(3): 349-351
Freymuth, F.; Moulin, M.A.; Morel, C.; Savini, E.C. 1970: Formulation of the antibacterial spectrum of antibiotics: rifamycins, gentamycin, sodium fusidate, kitasamycin, virginiamycin, pristinamycin, mikamycin, amfomycin Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(11): 2244-2249
Shek, P.N. 1977: Enhancement of the DNA synthetic response of antigen-primed lymph node cells by splenic promoter cells: characterization of the splenic promoter cells Journal of Immunology 119(1): 83-90
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Rizzino, A.; Kazakoff, P.; Ruff, E.; Kuszynski, C.; Nebelsick, J. 1988: Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor Cancer Research 48(15): 4266-4271